---
title: "DEZHAN HEALTHCARE: The relevant experiments for the IND application of WYY injection for stroke indications have been basically completed, and the clinical trial application is expected to be submitted in the second half of the year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259236105.md"
description: "36Kr learned that DEZHAN HEALTHCARE stated on the interactive platform that the relevant experiments for the IND application of WYY injection for stroke indications have been basically completed, and the clinical trial application is expected to be submitted in the second half of the year"
datetime: "2025-09-29T01:06:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259236105.md)
  - [en](https://longbridge.com/en/news/259236105.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259236105.md)
generator: "portal-rs"
---

# DEZHAN HEALTHCARE: The relevant experiments for the IND application of WYY injection for stroke indications have been basically completed, and the clinical trial application is expected to be submitted in the second half of the year

36Kr learned that DEZHAN HEALTHCARE stated on the interactive platform that the relevant experiments for the IND application of WYY injection for stroke indications have been basically completed, and the clinical trial application is expected to be submitted in the second half of the year

### Related Stocks

- [000813.CN](https://longbridge.com/en/quote/000813.CN.md)

## Related News & Research

- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [Vector Science files US provisional patent for orthopedic tissue-regeneration peptide platform](https://longbridge.com/en/news/296483037.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)
- [CTT Pharmaceutical CEO Ryan Khouri acquires 10,000 common shares for $590](https://longbridge.com/en/news/296370127.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**